Trends in breast cancer death rates from ductal carcinoma in situ versus invasive cancer in the United States | Breast Cancer Research
Data source and study participants To examine the trend in death rate from DCIS among women, we used…
Novartis to showcase transformative data in advanced prostate and early breast cancer at ESMO 2025
Key data from PSMAddition has been selected for a Presidential session; data to showcase the efficacy and safety…
“Junk DNA” Provides Surprising New Treatments for Hard-To-Treat Blood Cancers
Researchers at King’s College London have uncovered a surprising vulnerability in certain blood cancers by targeting a part…
Ireland’s ‘Viagra Village’ in the eye of Trump’s tariff storm – politico.eu
Ireland’s ‘Viagra Village’ in the eye of Trump’s tariff storm politico.euWhat Trends Are You Seeing in Pharma Commercialization? PharmExecIreland faces…
Regular mammograms linked to longer survival in women over 80
For many older women, the question of whether to continue breast cancer screening has been uncertain. While most…
Reticulocalbin-1 in clear cell renal cell carcinoma: clinical and functional evidence for its role as a biomarker and potential therapeutic target | BMC Cancer
Despite therapeutic advancements, the prognosis for metastatic ccRCC remains poor, with a 5-year survival rate of approximately 12–20…
Preventing radiation damage with melanin-based material
Radiotherapy for abdominal and pelvic cancers almost always leads to small-intestine injuries that are difficult to heal,…
Study identifies immune biomarkers for personalized therapies in pediatric germ cell tumors
A study conducted by the Molecular Oncology Research Center (CPOM) at Hospital de Amor in Barretos (formerly Barretos…
Multi-modal characterization of metabolic and immune gene clusters in adrenocortical carcinoma treatment
Establishment of the TIME subtype According to recent literature, knowledge of the TIME should be the main emphasis…
Casdatifan/Cabozantinib Shows Efficacy in Pretreated ccRCC
Casdatifan in combination with cabozantinib (Cabometyx) generated responses and was associated with a manageable safety profile in patients…
Expanding Patient Access to Comprehensive Genomic Profiling
Comprehensive genomic profiling (CGP) is reshaping cancer care by enhancing diagnostic accuracy, informing prognosis, and enabling more personalized…
Early ctDNA Status May Guide Consolidation Immunotherapy for Limited-Stage SCLC
Credit: Deep AI Measuring circulating tumor (ct) DNA after induction chemotherapy could identify the best candidates for consolidation…